In last trading session, scPharmaceuticals Inc (NASDAQ:SCPH) saw 0.4 million shares changing hands with its beta currently measuring 0.39. Company’s recent per share price level of $3.25 trading at -$0.11 or -3.27% at ring of the bell on the day assigns it a market valuation of $162.63M. That closing price of SCPH’s stock is at a discount of -101.23% from its 52-week high price of $6.54 and is indicating a premium of 5.23% from its 52-week low price of $3.08.

For scPharmaceuticals Inc (SCPH), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.39 in the current quarter.

scPharmaceuticals Inc (NASDAQ:SCPH) trade information

Upright in the red during last session for losing -3.27%, in the last five days SCPH remained trading in the red while hitting it’s week-highest on Tuesday, 02/18/25 when the stock touched $3.25 price level, adding 13.56% to its value on the day. scPharmaceuticals Inc’s shares saw a change of -8.19% in year-to-date performance and have moved -11.68% in past 5-day. scPharmaceuticals Inc (NASDAQ:SCPH) showed a performance of 1.25% in past 30-days.

Wall Street analysts have assigned a consensus price target of 13 to the stock, which implies a rise of 75.0% to its current value. Analysts have been projecting 13 as a low price target for the stock while placing it at a high target of 13. It follows that stock’s current price would drop -300.0% in reaching the projected high whereas dropping to the targeted low would mean a loss of -300.0% for stock’s current value.

scPharmaceuticals Inc (SCPH) estimates and forecasts

This year revenue growth is estimated to rise 166.77% from the last financial year’s standing.

5 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 12.08M for the same. And 3 analysts are in estimates of company making revenue of 13.93M in the next quarter. Company posted 6.1M and 6.1M of sales in current and next quarters respectively a year earlier.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 2.15% during past 5 years.

scPharmaceuticals Inc (NASDAQ:SCPH)’s Major holders

ORBIMED ADVISORS LLC is the top institutional holder at SCPH for having 5.56 million shares of worth $24.18 million. And as of 2024-06-30, it was holding 14.2608 of the company’s outstanding shares.

The second largest institutional holder is RUBRIC CAPITAL MANAGEMENT LP, which was holding about 3.52 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.042 of outstanding shares, having a total worth of $15.33 million.

On the other hand, Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 1.14 shares of worth $3.7 million or 2.28% of the total outstanding shares. The later fund manager was in possession of 754.57 shares on Nov 30, 2024 , making its stake of worth around $2.45 million in the company or a holder of 1.51% of company’s stock.